American Century Companies Inc Crinetics Pharmaceuticals, Inc. Transaction History
American Century Companies Inc
- $168 Billion
- Q4 2024
A detailed history of American Century Companies Inc transactions in Crinetics Pharmaceuticals, Inc. stock. As of the latest transaction made, American Century Companies Inc holds 477,298 shares of CRNX stock, worth $16.8 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
477,298
Previous 386,886
23.37%
Holding current value
$16.8 Million
Previous $19.8 Million
23.49%
% of portfolio
0.01%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding CRNX
# of Institutions
252Shares Held
89.2MCall Options Held
26.1KPut Options Held
11.8K-
Vanguard Group Inc Valley Forge, PA9.09MShares$320 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA6.95MShares$245 Million0.07% of portfolio
-
Black Rock Inc. New York, NY6.23MShares$219 Million0.01% of portfolio
-
Driehaus Capital Management LLC Chicago, IL6.14MShares$216 Million3.06% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.41MShares$191 Million0.03% of portfolio
About Crinetics Pharmaceuticals, Inc.
- Ticker CRNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,752,800
- Market Cap $1.89B
- Description
- Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...